AGP Picks
View all

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
6 hours ago

628th Medical Group mitigates vector-borne illnesses at Joint Base Charleston

DVIDS - Georgia

fallback image
9 hours ago

MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment

GlobeNewswire, Inc.

fallback image
6 hours ago

EMS Air Ambulance Completes 9,840 km Medical Repatriation from London to San Francisco for Elderly Trauma Patient

GlobeNewswire, Inc.

fallback image
9 hours ago

Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission

GlobeNewswire, Inc.

fallback image
7 hours ago

Wallace Subaru of Johnson City Donates $27,250 to Niswonger Children’s Hospital

EIN Presswire

fallback image
7 hours ago

Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial

GlobeNewswire, Inc.

fallback image
8 hours ago

First-in-the-World Gene Therapy Delivers Missing Gene Directly to Infant's Brain, Marking Historic Milestone in Precision Medicine

GlobeNewswire, Inc.

fallback image
12 hours ago

Medical Billing Outsourcing Market to reach USD 33.89 Billion by 2035 at 10.35% CAGR

EIN Presswire

fallback image
8 hours ago

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress

GlobeNewswire, Inc.

fallback image
8 hours ago

Kanza AI’s Clinical Reasoning System Launches with Lightning AI on NVIDIA Infrastructure in the US

GlobeNewswire, Inc.

fallback image
8 hours ago

Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet

GlobeNewswire, Inc.

fallback image
8 hours ago

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

GlobeNewswire, Inc.

fallback image
8 hours ago

Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1

GlobeNewswire, Inc.

fallback image
9 hours ago

Longevitix Launches Clinical Intelligence Platform for Preventive and Longevity Medicine

GlobeNewswire, Inc.

fallback image
9 hours ago

National Medical Waste Disposal Company Urges Sharps Safety Guidance for Texas Healthcare Facilities

EIN Presswire

fallback image
9 hours ago

Navy Medicine Readiness and Training Unit Portsmouth Earns Top Marks in Radiation Health Audit

DVIDS - Georgia

fallback image
9 hours ago

Totaligent Announces Featured Speaking Role at U.S.–Taiwan Innovation Forum, Advancing Global Biologics and Medical Tourism Collaboration

GlobeNewswire, Inc.

fallback image
9 hours ago

Sleepal® AI Lamp Recognized Kickstarter Project We Love - Award-Winning Clinically Validated Contactless Sleep System

EIN Presswire

fallback image
10 hours ago

Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes

GlobeNewswire, Inc.

fallback image
10 hours ago

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

GlobeNewswire, Inc.

Sign up for:

Healthcare Online Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page: